Yang L., Rozenfeld R., Wu D., Devi LAS., Zhang Z. Cederbaun A.: Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med. 2014, 68:260-7, PMID 24398069.

Raiesh M., Mukhopadhyay P., Bátjai S., Patel V., Saito K., Matsumoto S., Kashiwaya Y., Horváth B., Mukhopadhyay B., Becker L., Haskó G., Liaudet L., Wink DA., Veves A., Mecholam R., Pacher P.: Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death pathways in diabetic cardiomyopathy. J Am Coll Cardiol 2010; 56(25):2115-25. PMID 21144973.

Wang PF., Jiang LS., Bu J., Huang XJ., Song W., Du YP., He B.: Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury. J Cardiovasc Pharmacol. 2012; 59(4):301-7. PMID 22113346.

  1. ^ Jump up to: a b c d Pacher, P.; Bátkai, S; Kunos, G (2006). „The Endocannabinoid System as an Emerging Target of Pharmacotherapy“. Pharmacological Reviews 58 (3): 389–462. doi:1124/pr.58.3.2. PMC2241751. PMID 16968947. 
  2. ^ Jump up to: a b Lambert, Didier M.; Fowler, Christopher J. (2005). „The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications“. Journal of Medicinal Chemistry 48 (16): 5059–87. doi:1021/jm058183t. PMID16078824. 
  3. Jump up ^ Pertwee, Roger, ed. (2005). Cannabinoids. Springer-Verlag. p. 2. ISBN3-540-22565-X. 
  4. Jump up ^ „Bulletin on Narcotics – 1962 Issue 3 – 004“. UNODC (United Nations Office of Drugs and Crime). 1962-01-01. Retrieved 2014-01-15.
  5. ^ Jump up to: a b Aizpurua-Olaizola, Oier; Soydaner, Umut; Öztürk, Ekin; Schibano, Daniele; Simsir, Yilmaz; Navarro, Patricia; Etxebarria, Nestor; Usobiaga, Aresatz (2016-02-02). „Evolution of the Cannabinoid and Terpene Content during the Growth ofCannabis sativaPlants from Different Chemotypes“. Journal of Natural Products 79 (2): 324–331. doi:1021/acs.jnatprod.5b00949.
  6. ^ Jump up to: a b Devane, WA; Dysarz, FA 3rd; Johnson, MR; Melvin, LS; Howlett, AC (1988). „Determination and characterization of a cannabinoid receptor in rat brain“. Mol Pharmacol 34 (5): 605–13. PMID2848184. Retrieved 6 June 2015. 
  7. Jump up ^ Begg, Malcolm; Pacher, Pál; Batkai, Sándor; Oseihyiaman, Douglas; Offertaler, László; Mo, Fong Ming; Liu, Jie; Kunos, George (2005). „Evidence for novel cannabinoid receptors“. Pharmacology & Therapeutics 106 (2): 133–45. doi:1016/j.pharmthera.2004.11.005. PMID15866316. 
  8. Jump up ^ Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. p. 331. ISBN978-1-4160-3115-4. 
  9. ^ Jump up to: a b Pacher, P.; Mechoulam, R. (2011). „Is lipid signaling through cannabinoid 2 receptors part of a protective system?“. Progress in Lipid Research 50 (2): 193–211. doi:1016/j.plipres.2011.01.001. PMC3062638. PMID 21295074. 
  10. Jump up ^ Núñez, Estefanía; Benito, Cristina; Pazos, M. Ruth; Barbachano, Antonio; Fajardo, Otto; González, Sara; Tolón, Rosa M.; Romero, Julián (2004). „Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study“. Synapse 53 (4): 208–13. doi:1002/syn.20050. PMID15266552. 
  11. Jump up ^ Fellermeier, Monika; Eisenreich, Wolfgang; Bacher, Adelbert; Zenk, Meinhart H. (2001). „Biosynthesis of cannabinoids“. European Journal of Biochemistry 268 (6): 1596–1604. doi:1046/j.1432-1327.2001.02030.x. ISSN0014-2956. PMID 11248677. 
  12. Jump up ^ Patent application title: Controlled cannabis decarboxylation. US Patent application number: 20120046352. Retrieved 28 December 2013
  13. ^ Jump up to: a b Iseger, TA; Bossong, MG (March 2015). „A systematic review of the antipsychotic properties of cannabidiol in humans.“. Schizophrenia Research 162 (1-3): 153–61. doi:1016/j.schres.2015.01.033. PMID25667194.  |access-date= requires |url= (help)
  14. ^ Jump up to: a b c Mechoulam, Raphael; Peters, Maximilian; Murillo-Rodriguez, Eric; Hanuš, Lumír O. (2007). „Cannabidiol – Recent Advances“. Chemistry & Biodiversity 4 (8): 1678–92. doi:1002/cbdv.200790147. PMID17712814. 
  15. Jump up ^ Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, N-O; Leonova, J; Elebring, T; Nilsson, K; Drmota, T; Greasley, P J (2009). „The orphan receptor GPR55 is a novel cannabinoid receptor“. British Journal of Pharmacology 152 (7): 1092–101. doi:1038/sj.bjp.0707460. PMC2095107. PMID 17876302. 
  16. Jump up ^ Russo, Ethan B.; Burnett, Andrea; Hall, Brian; Parker, Keith K. (2005). „Agonistic Properties of Cannabidiol at 5-HT1a Receptors“. Neurochemical Research 30 (8): 1037–43. doi:1007/s11064-005-6978-1. PMID16258853. 
  17. Jump up ^ Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006). „Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma“. The Journal of Pharmacology and Experimental Therapeutics 318 (3): 1375–87. doi:1124/jpet.106.105247. PMID16728591. 
  18. Jump up ^ Frood, Arron. „Key ingredient staves off marijuana memory loss“. Nature. Retrieved 6 October 2015.
  19. Jump up ^ McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K (2014). „Cannabis and schizophrenia“. Cochrane Database Syst Rev 10: CD004837. doi:1002/14651858.CD004837.pub3. PMID25314586. 
  20. Jump up ^ Mahadevan, Anu; Siegel, Craig; Martin, Billy R.; Abood, Mary E.; Beletskaya, Irina; Razdan, Raj K. (2000). „Novel Cannabinol Probes for CB1 and CB2 Cannabinoid Receptors“. Journal of Medicinal Chemistry 43 (20): 3778–85. doi:1021/jm0001572. PMID11020293. 
  21. Jump up ^ Borrelli F, Pagano E, Romano B, Panzera S, Maiello F, Coppola D, De Petrocellis L, Buono L, Orlando P, Izzo AA (2014). „Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid“. Carcinogenesis 35 (12): 2787–97. doi:1093/carcin/bgu205. PMID25269802. 
  22. ^ Jump up to: a b Cascio, MG; Gauson, LA; Stevenson, LA; Ross, RA; Pertwee, RG (2010). „Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist“. British Journal of Pharmacology 159 (1): 129–41. doi:1111/j.1476-5381.2009.00515.x. PMC2823359. PMID 20002104. 
  23. Jump up ^ Baker, PB; Gough, TA; Taylor, BJ (1980). „Illicitly imported Cannabis products: Some physical and chemical features indicative of their origin“. Bulletin on narcotics 32 (2): 31–40. PMID6907024. 
  24. ^ Jump up to: a b Hillig, K. W.; Mahlberg, P. G. (2004). „A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)“. American Journal of Botany 91 (6): 966–75. doi:3732/ajb.91.6.966. PMID21653452. 
  25. Jump up ^ Thomas, Adèle; Stevenson, Lesley A; Wease, Kerrie N; Price, Martin R; Baillie, Gemma; Ross, Ruth A; Pertwee, Roger G (2005). „Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist“. British Journal of Pharmacology 146 (7): 917–26. doi:1038/sj.bjp.0706414. PMC1751228. PMID 16205722. 
  26. Jump up ^ Merkus, Frans W. H. M. (1971). „Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish“. Nature 232 (5312): 579–80. doi:1038/232579a0. PMID4937510. 
  27. Jump up ^ Ilan, A. B.; Gevins, A.; Coleman, M.; Elsohly, M. A.; De Wit, H. (2005). „Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids“. Behavioural Pharmacology 16 (5–6): 487–96. doi:1097/00008877-200509000-00023. PMID16148455. 
  28. Jump up ^ http://jpet.aspetjournals.org/content/318/3/1375.long
  29. ^ Jump up to: a b Bauer, Rudolf; Salo-Ahen, Karin; Bauer, Outi (2008). „CB Receptor Ligands from Plants“. Current Topics in Medicinal Chemistry 8 (3): 173–86. doi:2174/156802608783498023. PMID18289087. 
  30. Jump up ^ Bauer, R.; Remiger, P. (2007). „TLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2“. Planta Medica 55 (4): 367–71. doi:1055/s-2006-962030. PMID17262436. 
  31. Jump up ^ Raduner, S; Majewska, A; Chen, J; Xie, X; Hamon, J; Faller, B; Altmann, K; Gertsch, J (2006). „Alkylamides from Echinacea Are a New Class of Cannabinomimetics: CANNABINOID TYPE 2 RECEPTOR-DEPENDENT AND -INDEPENDENT IMMUNOMODULATORY EFFECTS“ (PDF). J. Biol. Chem. 281 (20): 14192–14206. doi:1074/jbc.M601074200. PMID16547349. 
  32. Jump up ^ Perry, Nigel; Van Klink, John; Burgess, Elaine; Parmenter, Graeme (2007). „Alkamide Levels inEchinacea purpurea: A Rapid Analytical Method Revealing Differences among Roots, Rhizomes, Stems, Leaves and Flowers“. Planta Medica 63 (1): 58–62. doi:1055/s-2006-957605. PMID17252329. 
  33. Jump up ^ He, X; Lin, L; Bernart, MW; Lian, L (1998). „Analysis of alkamides in roots and achenes of Echinacea purpurea by liquid chromatography–electrospray mass spectrometry“. Journal of Chromatography A 815 (2): 205–11. doi:1016/S0021-9673(98)00447-6.
  34. Jump up ^ Ligresti, A.; Villano, R.; Allarà, M.; Ujváry, I. N.; Di Marzo, V. (2012). „Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand“. Pharmacological Research 66 (2): 163–169. doi:1016/j.phrs.2012.04.003. PMID22525682. 
  35. Jump up ^ Korte, G.; Dreiseitel, A.; Schreier, P.; Oehme, A.; Locher, S.; Geiger, S.; Heilmann, J.; Sand, P.G. (2010). „Tea catechins‘ affinity for human cannabinoid receptors“. Phytomedicine 17 (1): 19–22. doi:1016/j.phymed.2009.10.001. PMID19897346. 
  36. Jump up ^ Gertsch, J; Leonti, M; Raduner, S; Racz, I; Chen, J; Xie, X; Altmann, K; Karsak, M; Zimmer, A (2008). „Beta-caryophyllene is a dietary terpene“. PNAS 105 (26): 9099–9104. doi:1073/pnas.0803601105. PMC2449371. PMID 18574142. 
  37. Jump up ^ Truffles contain endocannabinoid metabolic enzymes and anandamide Phytochemistry, Available online 26 November 2014.
  38. ^ Jump up to: a b Stout, Stephen M.; Cimino, Nina M. (2014-02-01). „Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review“. Drug Metabolism Reviews 46 (1): 86–95. doi:3109/03602532.2013.849268. ISSN0360-2532. PMID 24160757. 
  39. Jump up ^ Ashton CH (February 2001). „Pharmacology and effects of cannabis: a brief review“. Br J Psychiatry 178 (2): 101–106. doi:1192/bjp.178.2.101. PMID11157422. Because they are extremely lipid soluble, cannabinoids accumulate in fatty tissues, reaching peak concentrations in 4-5 days. They are then slowly released back into other body compartments, including the brain. They are then slowly released back into other body compartments, including the brain. Because of the sequestration in fat, the tissue elimination half-life of THC is about 7 days, and complete elimination of a single dose may take up to 30 days. 
  40. Jump up ^ Katona I, Freund TF (2012). „Multiple functions of endocannabinoid signaling in the brain“. Annual Review of Neuroscience 35: 529–58. doi:1146/annurev-neuro-062111-150420. PMC4273654. PMID 22524785. 
  41. ^ Jump up to: a b c Grotenhermen, Franjo (2005). „Cannabinoids“. Current Drug Target -CNS & Neurological Disorders 4 (5): 507–530. doi:2174/156800705774322111.
  42. Jump up ^ Martin, B.R.; Mechoulam, R.; Razdan, R.K. (1999). „Discovery and characterization of endogenous cannabinoids“. Life Sciences 65 (6–7): 573–595. doi:1016/S0024-3205(99)00281-7.
  43. Jump up ^ Di Tomaso, Emmanuelle; Beltramo, Massimiliano; Piomelli, Daniele (1996). „Brain cannabinoids in chocolate“. Nature 382 (6593): 677–8. doi:1038/382677a0. PMID8751435. 
  44. Jump up ^ Chapman, K. D.; Venables, B; Markovic, R; Blair Jr, RW; Bettinger, C (1999). „N-Acylethanolamines in Seeds. Quantification of Molecular Species and Their Degradation upon Imbibition“. Plant Physiology 120 (4): 1157–64. doi:1104/pp.120.4.1157. PMC59349. PMID 10444099. 
  45. Jump up ^ Sepe, Nunzio; De Petrocellis, Luciano; Montanaro, Francesca; Cimino, Guido; Di Marzo, Vincenzo (1998). „Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs“. Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism 1389 (2): 101–11. doi:1016/S0005-2760(97)00132-X. PMID9461251. 
  46. Jump up ^ Piomelli, Daniele; Schweitzer, Nephi; Piomelli, Paul (1997). „A second endogenous cannabinoid that modulates long-term potentiation“. Nature 388 (6644): 773–8. doi:1038/42015. PMID9285589. 
  47. Jump up ^ Savinainen, Juha R; Järvinen, Tomi; Laine, Krista; Laitinen, Jarmo T (2001). „Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1receptor-dependent G-protein activation in rat cerebellar membranes“. British Journal of Pharmacology 134 (3): 664–72. doi:1038/sj.bjp.0704297. PMC1572991. PMID 11588122. 
  48. Jump up ^ Hanuš, Lumír; Abu-Lafi, Saleh; Fride, Ester; Breuer, Aviva; Vogel, Zvi; Shalev, Deborah E.; Kustanovich, Irina; Mechoulam, Raphael (2001). „2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor“. Proceedings of the National Academy of Sciences 98 (7): 3662–5. doi:1073/pnas.061029898. PMC31108. PMID 11259648. 
  49. Jump up ^ Oka, Saori; Tsuchie, Akiko; Tokumura, Akira; Muramatsu, Mayumi; Suhara, Yoshitomo; Takayama, Hiroaki; Waku, Keizo; Sugiura, Takayuki (2003). „Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species“. Journal of Neurochemistry 85 (6): 1374–81. doi:1046/j.1471-4159.2003.01804.x. PMID12787057. 
  50. Jump up ^ Bisogno, Tiziana; Melck, Dominique; Bobrov, Mikhail Yu.; Gretskaya, Natalia M.; Bezuglov, Vladimir V.; De Petrocellis, Luciano; Di Marzo, Vincenzo (2000). „N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo“. Biochemical Journal 351 (3): 817–24. doi:1042/0264-6021:3510817. PMC1221424. PMID 11042139. 
  51. Jump up ^ Bisogno, T; Ligresti, A; Dimarzo, V (2005). „The endocannabinoid signalling system: Biochemical aspects“. Pharmacology Biochemistry and Behavior 81 (2): 224–38. doi:1016/j.pbb.2005.01.027. PMID15935454. 
  52. Jump up ^ Ralevic, Vera (2003). „Cannabinoid modulation of peripheral autonomic and sensory neurotransmission“. European Journal of Pharmacology 472 (1–2): 1–21. doi:1016/S0014-2999(03)01813-2. PMID12860468. 
  53. Jump up ^ Porter, A. C.; Sauer, JM; Knierman, MD; Becker, GW; Berna, MJ; Bao, J; Nomikos, GG; Carter, P; Bymaster, FP; Leese, AB; Felder, CC (2002). „Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor“. Journal of Pharmacology and Experimental Therapeutics 301 (3): 1020–4. doi:1124/jpet.301.3.1020. PMID12023533. 
  54. Jump up ^ Piñeiro, Roberto; Falasca, Marco (2012). „Lysophosphatidylinositol signalling: New wine from an old bottle“. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids 1821 (4): 694–705. doi:1016/j.bbalip.2012.01.009. PMID22285325. 
  55. Jump up ^ Fride, E; Bregman, T; Kirkham, TC (2005). „Endocannabinoids and food intake: Newborn suckling and appetite regulation in adulthood“. Experimental biology and medicine 230 (4): 225–34. PMID15792943. 
  56. Jump up ^ ElSohly, Mahmoud A.; Gul, Waseem; Wanas, Amira S.; Radwan, Mohamed M. (2014-02-27). „Synthetic cannabinoids: Analysis and metabolites“. Life Sciences. Special Issue: Emerging Trends in the Abuse of Designer Drugs and Their Catastrophic Health Effects: Update on Chemistry, Pharmacology, Toxicology and Addiction Potential 97 (1): 78–90. doi:1016/j.lfs.2013.12.212.
  57. Jump up ^ Lauritsen, Kirstin J.; Rosenberg, Harold (2016-02-24). „Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana“. The American Journal of Drug and Alcohol Abuse 0 (0): 1–8. doi:3109/00952990.2015.1135158. ISSN0095-2990. PMID 26910181. 
  58. ^ Jump up to: a b „N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide(AB-CHMINACA), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)and[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone(THJ-2201)“ (PDF). Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration. December 2014.Jump up ^ „More medicinal uses for marijuana“. Marijuana.org. October 18, 2005. Archived from the original on 2005-12-21. Retrieved 2014-01-15.